BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Icalcaprant readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Icalcaprant\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07276997-837@assetmemo.bio
DTSTAMP:20261121T004432Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Icalcaprant: Phase 2 readout est. (NCT07276997)
DESCRIPTION:Icalcaprant\, phase 2\, Major Depressive Disorder.\nStudy: A St
 udy to Assess Change in Disease Activity and Adverse Events of Oral Icalca
 prant in Adult Participants With Major Depressive Disorder\nEstimated prim
 ary completion: September 2027. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/icalcaprant#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07276997
URL:https://assetmemo.bio/drug/icalcaprant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06696755-837@assetmemo.bio
DTSTAMP:20261121T004432Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Icalcaprant: Phase 2 readout est. (NCT06696755)
DESCRIPTION:Icalcaprant\, phase 2\, Bipolar Disorder.\nStudy: A Study to As
 sess Adverse Events and Change in Disease Activity of Oral Icalcaprant in 
 Adult Participants With Bipolar I or II Disorder\nEstimated primary comple
 tion: November 2027. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 icalcaprant#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT06696755
URL:https://assetmemo.bio/drug/icalcaprant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
